Brand name: Logynon ED
Logynon ED is a medicine containing the active ingredient(s) levonorgestrel + ethinylestradiol. On this page you will find out more about Logynon ED, including side effects, age restrictions, food interactions and whether the medicine is subsidised by the government on the pharmaceutical benefits scheme (PBS)
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional. healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.
Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions.
Active ingredient in this medicine: levonorgestrel + ethinylestradiol
Information for medicine and pack size:
Logynon ED (6 x 50 microgram/30 microgram tablets, 5 x 75 microgram/40 microgram tablets, 10 x 125 microgram/30 microgram tablets, 7 x inert tablets), 4 x 28
Consumer Medicine Information leaflet:
This leaflet may also be found inside the medicine package. It contains information on side effects, age restrictions and other useful data.
What this medicine is for
Oral contraception.
Table of characteristics
| Active ingredient | |
|---|---|
| Medicine schedule |
1 x 28 tablets: Prescription Only Medicine, or Prescription Animal Remedy
4 x 28 tablets: Prescription Only Medicine, or Prescription Animal Remedy
|
Part 1
| Visual appearance | Ochre, biconvex, round tablet |
|---|---|
| Dosage Form | Tablet, sugar coated |
| Route of administration | Oral |
Part 2
| Visual appearance | White, biconvex, round tablet |
|---|---|
| Dosage Form | Tablet, sugar coated |
| Route of administration | Oral |
Part 3
| Visual appearance | White, biconvex, round tablet |
|---|---|
| Dosage Form | Tablet, sugar coated |
| Route of administration | Oral |
Part 4
| Visual appearance | Light brown, biconvex, round tablets |
|---|---|
| Dosage Form | Tablet, sugar coated |
| Route of administration | Oral |
There is one type of pack available.
Pack type 1
| Type | Blister Pack |
|---|---|
| Storage temperature | Store below 30 degrees Celsius |
| Storage conditions | No information available |
| Life time | 5 Years |
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on 1 October 2017
The PBS provides a list of government subsidised medicines available to be dispensed to patients. Further information can be found on the Pharmaceutical Benefits Scheme website.
Is this medication banned in sport?
Check if you can use your medicine whilst playing sport. Search the Australian Sports Anti-Doping Authority (ASADA) database that provides information about the prohibited status of specific medications and/or the active ingredient based on the current World Anti-Doping Agency (WADA) Prohibited List.
Need more information?
These trusted information partners have more on this topic.
